Background
Monsanto Company held patents on Roundup Ready soybeans — a genetically modified soybean variety engineered to tolerate the herbicide glyphosate (Roundup). Farmers who purchased Roundup Ready seeds from Monsanto or authorized dealers signed a Technology Use Agreement (TUA) agreeing not to save or replant seeds from the harvested crop. Homan McFarling and Mitchell Scruggs were Mississippi and Alabama farmers who purchased Roundup Ready seeds but saved a portion of each year’s harvest and replanted those saved seeds in subsequent seasons, in violation of their TUAs.
Monsanto sued for patent infringement. The farmers argued, among other things, that Monsanto’s patent rights in the purchased seeds were exhausted by the first authorized sale — meaning they had the right to do whatever they wished with the purchased seeds, including save and replant them. Monsanto countered that exhaustion applied only to the first generation of purchased seeds, not to the progeny seeds grown from them.
The Court’s Holding
The Federal Circuit affirmed infringement. The court held that the patent exhaustion doctrine does not apply to second-generation seeds — seeds grown from an authorized purchase. When a farmer purchases an authorized Roundup Ready seed, exhaustion applies to that seed only. But new seeds grown by that plant using the patented genetic technology are new embodiments of the patented invention, not the same article that was sold. Exhaustion does not extend to these new articles, which are made anew (through biological reproduction) rather than resold.
The court also upheld the TUA restriction on seed saving as a valid contractual term — noting that even if some exhaustion argument were available, the contractual restriction independently prohibited seed saving and was enforceable as a condition of the license under which the farmer purchased the seeds.
Key Takeaways
- Patent exhaustion does not apply to second-generation seeds grown from authorized purchases of patented GMO seeds — each new generation of seeds is a new embodiment of the patented invention, not an article whose resale is governed by the first-sale exhaustion doctrine.
- Technology use agreements restricting seed saving are valid and enforceable as license conditions — farmers who purchase patented seeds subject to seed-saving restrictions cannot invoke exhaustion to override those contractual terms.
- The Monsanto v. Scruggs framework for biotechnology seed patents was later confirmed by the Supreme Court in Bowman v. Monsanto (2013), which rejected the argument that self-replicating patented technology falls outside the patent system upon first authorized sale.
- Agricultural biotech patent holders can rely on both patent infringement (for unauthorized replanting of patented seeds) and breach of license agreement claims against seed-saving farmers — providing dual enforcement mechanisms for protecting patented crop genetics.
Why It Matters
Monsanto v. Scruggs was one of a series of Federal Circuit and district court decisions in the 2000s establishing the legal framework for enforcing agricultural biotechnology patents against seed-saving farmers — a practice with ancient agricultural roots that became economically and legally contested with the commercialization of patented GMO seed technology. By confirming that exhaustion does not apply to second-generation seeds, the court gave biotech seed companies the legal tools to enforce their technology use agreements and protect the economic model on which billions of dollars of agricultural biotechnology investment depended.
The case is part of a broader pattern of decisions (including the Supreme Court’s Bowman v. Monsanto in 2013) establishing that self-replicating patented technologies do not fall outside patent protection through the exhaustion doctrine upon first sale — a principle with implications not just for agricultural seed patents but for any patented technology that can reproduce, copy, or multiply itself after an authorized initial sale.